| Item type |
[ELS]学術雑誌論文 / Journal Article(1) |
| 公開日 |
2017-05-24 |
| タイトル |
|
|
タイトル |
Effect of Oral Procaterol in Combination with Inhaled Corticosteroids in Adult Patients with Bronchial Asthma |
|
言語 |
en |
| 言語 |
|
|
言語 |
eng |
| キーワード |
|
|
言語 |
en |
|
主題 |
oral b2-agonist |
| キーワード |
|
|
言語 |
en |
|
主題 |
procaterol |
| キーワード |
|
|
言語 |
en |
|
主題 |
bronchial asthma |
| キーワード |
|
|
言語 |
en |
|
主題 |
inhaled corticosteroids |
| キーワード |
|
|
言語 |
en |
|
主題 |
combination therapy |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| 雑誌書誌ID |
|
|
収録物識別子 |
AA00629581 |
| 論文名よみ |
|
|
タイトル |
Effect of Oral Procaterol in Combination with Inhaled Corticosteroids in Adult Patients with Bronchial Asthma |
| 著者 |
Sagara, Hironori
Okada, Takenori
Sugiyama, Kumiya
Ohta, Mayumi
Kashima, Ryuichi
Yukawa, Tatsuo
Fukuda, Takeshi
|
| 著者所属(英) |
|
|
|
en |
|
|
Department of Pulmonary Medicine and Clinical Immunology,Dokkyo Medical University |
| 著者所属(英) |
|
|
|
en |
|
|
Department of Pulmonary Medicine and Clinical Immunology,Dokkyo Medical University |
| 著者所属(英) |
|
|
|
en |
|
|
Department of Pulmonary Medicine and Clinical Immunology,Dokkyo Medical University |
| 著者所属(英) |
|
|
|
en |
|
|
Department of Pulmonary Medicine and Clinical Immunology,Dokkyo Medical University |
| 著者所属(英) |
|
|
|
en |
|
|
Department of Pulmonary Medicine and Clinical Immunology,Dokkyo Medical University |
| 著者所属(英) |
|
|
|
en |
|
|
Department of Pulmonary Medicine and Clinical Immunology,Dokkyo Medical University |
| 著者所属(英) |
|
|
|
en |
|
|
Department of Pulmonary Medicine and Clinical Immunology,Dokkyo Medical University |
| 記事種別(日) |
|
|
内容記述タイプ |
Other |
|
内容記述 |
原著 |
| 記事種別(英) |
|
|
内容記述タイプ |
Other |
|
内容記述 |
Original |
| 抄録(英) |
|
|
内容記述タイプ |
Other |
|
内容記述 |
Background:Bronchial asthma is considered to be a chronic airway inflammatory disease, and inhaledcorticosteroids play a central role in controlling airway inflammation. In some patients, however, it is difficultto control symptoms despite the use of moderate to high doses of inhaled corticosteroids. Long-actinginhaled b2-agonists have recently become available and reconsidered as a controller.Objectives:To examine whether combination of an inhaled corticosteroid and an oral b2-agonist can improvesymptoms in patients with moderate bronchial asthma whose airway obstructive symptoms cannotbe relieved sufficiently by inhaled corticosteroids alone.Methods:Of outpatients in our hospital with moderate bronchial asthma (step 3) given beclomethasoneat a daily dose of 800 mg, whose peak expiratory flow rate in the early morning was 70 % or less of the predictedvalue, 12 patients were enrolled in the study who showed at least 12.5 % improvement in the forcedexpiratory volume in one second (FEV1.0) after inhalation of 20 mg procaterol (Meptin Air from OtsukaPharma. Co.) for 15 minutes. Procaterol tablets (Meptin tablets, 50 mg from Otsuka Pharma. Co.) were administeredin the morning and before bed for 4 weeks, and change in the peak expiratory flow rate, subjectivesymptoms, respiratory function, and the number of puffs of the b2-agonist were evaluated.Results:The peak expiratory flow rate, FEV1.0, forced vital capacity (% FVC),and airway hyperresponsivenessimproved after coadministration of oral procaterol and beclomethasone.Conclusions:The oral b2-agonist in combination with an inhaled corticosteroid might improve asthmasymptoms better than inhaled corticosteroids alone. |
| 書誌情報 |
Dokkyo journal of medical sciences
巻 35,
号 3,
p. 153-159,
発行日 2008-10-25
|
| ISSN |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
03855023 |
KJ00006339179.pdf (146.4 kB)
